-
G651118-10mgGSK-3/CDK5/CDK2-IN-1, an imidazole derivative, is an inhibitor of cdk5 , cdk2 , and GSK-3 extracted from patent WO2002010141A1, example 9a. GSK-3/CDK5/CDK2-IN-1 can be used for the research of cancer , and neurodegenerative diseasesIn
-
G651118-25mgGSK-3/CDK5/CDK2-IN-1, an imidazole derivative, is an inhibitor of cdk5 , cdk2 , and GSK-3 extracted from patent WO2002010141A1, example 9a. GSK-3/CDK5/CDK2-IN-1 can be used for the research of cancer , and neurodegenerative diseasesIn
-
G651118-5mgGSK-3/CDK5/CDK2-IN-1, an imidazole derivative, is an inhibitor of cdk5 , cdk2 , and GSK-3 extracted from patent WO2002010141A1, example 9a. GSK-3/CDK5/CDK2-IN-1 can be used for the research of cancer , and neurodegenerative diseasesIn
-
G656537-1mlGSK-3/CDK5/CDK2-IN-1, an imidazole derivative, is an inhibitor of cdk5 , cdk2 , and GSK-3 extracted from patent WO2002010141A1, example 9a. GSK-3/CDK5/CDK2-IN-1 can be used for the research of cancer , and neurodegenerative diseasesIn
-
G651681-10mgGSK-3β inhibitor 1 (compound 3a) is a glycogen synthase kinase 3β (GSK-3β) inhibitor and demonstrates high antidiabetic efficacy, with an IC 50 of 4.9 nMForm:SolidIC50& Target:GSK-3β 4.9 nM (IC 50 )
-
G651681-50mgGSK-3β inhibitor 1 (compound 3a) is a glycogen synthase kinase 3β (GSK-3β) inhibitor and demonstrates high antidiabetic efficacy, with an IC 50 of 4.9 nMForm:SolidIC50& Target:GSK-3β 4.9 nM (IC 50 )
-
G651681-5mgGSK-3β inhibitor 1 (compound 3a) is a glycogen synthase kinase 3β (GSK-3β) inhibitor and demonstrates high antidiabetic efficacy, with an IC 50 of 4.9 nMForm:SolidIC50& Target:GSK-3β 4.9 nM (IC 50 )
-
G656777-1mlGSK-3β inhibitor 1 (compound 3a) is a glycogen synthase kinase 3β (GSK-3β) inhibitor and demonstrates high antidiabetic efficacy, with an IC 50 of 4.9 nMIC50& Target:GSK-3β 4.9 nM (IC 50 )
-
G649951-100mgGSK-3β inhibitor 2 (Compound 3) is a potent, selective and orally active GSK-3β inhibitor with an IC 50 of 1.1 nM. GSK-3β inhibitor 2 can cross the blood-brain barrier. GSK-3β inhibitor 2 has the potential for Alzheimer's diseaseIn VitroThe pyridine
-
G649951-10mgGSK-3β inhibitor 2 (Compound 3) is a potent, selective and orally active GSK-3β inhibitor with an IC 50 of 1.1 nM. GSK-3β inhibitor 2 can cross the blood-brain barrier. GSK-3β inhibitor 2 has the potential for Alzheimer's diseaseIn VitroThe pyridine
-
G649951-50mgGSK-3β inhibitor 2 (Compound 3) is a potent, selective and orally active GSK-3β inhibitor with an IC 50 of 1.1 nM. GSK-3β inhibitor 2 can cross the blood-brain barrier. GSK-3β inhibitor 2 has the potential for Alzheimer's diseaseIn VitroThe pyridine
-
G649951-5mgGSK-3β inhibitor 2 (Compound 3) is a potent, selective and orally active GSK-3β inhibitor with an IC 50 of 1.1 nM. GSK-3β inhibitor 2 can cross the blood-brain barrier. GSK-3β inhibitor 2 has the potential for Alzheimer's diseaseIn VitroThe pyridine